Goldman Sachs Group Inc. decreased its holdings in HCM II Acquisition Corp. (NASDAQ:HOND - Free Report) by 3.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 618,772 shares of the company's stock after selling 21,252 shares during the period. Goldman Sachs Group Inc. owned about 2.15% of HCM II Acquisition worth $6,509,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of HOND. Linden Advisors LP purchased a new position in shares of HCM II Acquisition in the 1st quarter worth $21,150,000. Magnetar Financial LLC purchased a new position in HCM II Acquisition during the first quarter valued at $20,719,000. MMCAP International Inc. SPC purchased a new position in HCM II Acquisition during the first quarter valued at $10,310,000. Encompass Capital Advisors LLC purchased a new position in HCM II Acquisition during the first quarter valued at $10,006,000. Finally, Calamos Advisors LLC purchased a new position in HCM II Acquisition during the first quarter valued at $5,288,000.
HCM II Acquisition Price Performance
Shares of HCM II Acquisition stock traded up $0.46 during trading hours on Friday, hitting $13.26. The company's stock had a trading volume of 1,095,929 shares, compared to its average volume of 343,177. The business has a 50 day moving average price of $11.43 and a two-hundred day moving average price of $11.10. HCM II Acquisition Corp. has a 12-month low of $9.90 and a 12-month high of $13.35.
HCM II Acquisition Company Profile
(
Free Report)
HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.
See Also

Before you consider HCM II Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCM II Acquisition wasn't on the list.
While HCM II Acquisition currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.